Related Experiment Videos
Placental transfer and maternal midazolam kinetics
Clinical Pharmacology and Therapeutics
|June 1, 1983
Summary
Midazolam provides effective nocturnal sedation for cesarean section patients, with minimal drug transfer to the fetus. This benzodiazepine ensures approximately 6 hours of sleep, with negligible levels detected the following morning.
Area of Science:
- Pharmacology
- Obstetrics
- Anesthesiology
Background:
- Benzodiazepines are commonly used for sedation in surgical procedures.
- Assessing the safety and efficacy of new sedative agents in pregnant populations is crucial.
- Midazolam is a newer benzodiazepine with potential applications in obstetric anesthesia.
Purpose of the Study:
- To evaluate the pharmacokinetic profile of midazolam in pregnant women undergoing elective cesarean section.
- To determine the extent of fetomaternal drug transfer after oral and intramuscular administration of midazolam.
- To assess the clinical utility of midazolam for nocturnal sedation prior to cesarean delivery.
Main Methods:
- Administered a single 15-mg oral dose of midazolam the evening before elective cesarean section.
- Measured midazolam levels in maternal and fetal serum at various time points.
- Compared midazolam pharmacokinetics with diazepam and assessed patient-reported outcomes.
Main Results:
- Midazolam levels were measurable in the fetomaternal unit in only 1 of 13 cases 12 hours after oral administration.
- Evidence of drug transfer into the placenta was observed, but at a slower rate than diazepam.
- Midazolam demonstrated a rapid onset and short duration of action, with significant interindividual variation in gastrointestinal absorption.
Conclusions:
- Midazolam is a clinically useful agent for nocturnal sedation before elective cesarean section.
- It ensures a mean sleep duration of approximately 6 hours.
- Virtually undetectable drug levels in the fetomaternal unit the next morning suggest a favorable safety profile.